Pharma SEO: unbranded pages win the condition search, branded pages must carry their risk information, and medical review sets the pace
How pharmaceutical SEO works for brand sites, disease awareness sites and HCP portals, which FDA and Google rules shape the pages, and what to ask a pharmaceutical SEO agency.
Published by AI Knows Us · Updated 22 October 2026
Pharma SEO is search optimisation for pharmaceutical brands, disease awareness sites and healthcare professional portals, done inside the rules that govern drug promotion. In practice it means three things. Build unbranded condition and disease pages that answer what patients actually search, because those searches dwarf brand searches before a diagnosis. Make branded product pages fast, well structured and complete, with the risk information placed alongside the benefit claims rather than buried. And plan the whole programme around medical, legal and regulatory review, because a page that takes eight weeks to approve needs a different content calendar from a retail blog. Google treats health as a topic where trust carries extra weight, so named medical reviewers, references and review dates belong on every page.
Why pharmaceutical SEO is its own discipline
Most SEO advice assumes you can publish what you like, change it tomorrow and promise whatever converts. Pharmaceutical companies cannot. Every promotional claim is reviewed against the approved labeling, benefits are presented with fair balance, and every change goes back through review. Three consequences shape the work:
- Organic search carries more weight than usual, because paid search for prescription drugs is restricted.
- Unbranded content does the heavy lifting early in the patient journey, before a patient knows a brand name.
- Speed of approval decides how fast you can publish. A competitor who can update a page in a week will out-publish one who takes a quarter.
The rules that shape the pages
This is general information, not regulatory advice. Your regulatory team decides how each rule applies to each asset.
FDA advertising rules. 21 CFR 202.1(e), read on 21 October 2026 through the eCFR, says that all advertisements for a prescription drug, other than the exempt kinds, 'must present a true statement of information in brief summary relating to side effects, contraindications', and effectiveness. One exemption is the reminder advertisement, which calls attention to the name of the drug but does not include indications or dosage recommendations. Section 202.1(l)(2) lists brochures, mailing pieces, bulletins, literature and similar printed, audio or visual matter descriptive of a drug, disseminated by or for the manufacturer, as labeling. Treat brand web pages with the same standards your regulatory team applies to those materials.
Google's healthcare and medicines policy. Read on 21 October 2026, it says Google 'doesn't allow the use of prescription drug terms in ad text, landing pages, or keywords', with exceptions: websites accessible only to healthcare professionals, brick-and-mortar pharmacies and pharmaceutical manufacturers may use prescription drug terms in keywords. It also says Google 'allows pharmaceutical manufacturers to advertise prescription drugs and over-the-counter medicines in select locations only' and that manufacturers 'must be certified by Google in order to serve ads'. That is why organic rankings for brand and condition terms matter so much in this industry.
Google's view of health content. Google's guide to creating helpful content says its systems give 'even more weight to content that aligns with strong E-E-A-T for topics that could significantly impact the health, financial stability, or safety of people'. It calls these 'Your Money or Your Life' topics. A medicine page is about as clear an example as exists.
The three kinds of pharma site and what each needs
| Site | Searches it answers | SEO priorities |
|---|---|---|
| Unbranded disease awareness | symptoms, causes, tests, treatment options, living with the condition | Depth, plain language, medical reviewer named, sources cited, no product promotion |
| Branded patient site | brand name, brand plus side effects, cost, savings card, how to take | Own every branded query, risk information with claims, fast pages, clear support and savings pages |
| HCP portal | dosing, mechanism of action, clinical data, prescribing information | Indexable summary pages, gated detail where required, structured clinical content |
Keep the unbranded and branded sites clearly separate in content and navigation. A disease awareness page that drifts into promoting a product becomes a promotional page, with all the review and disclosure that brings.
Keyword research for pharmaceutical brands
Patients and prescribers use different vocabularies. Patients search 'why am I always tired', 'is my rash eczema' and '[brand] side effects'. Prescribers search drug class, mechanism, dosing and trial names. Build separate keyword sets and separate page templates for each.
- Branded queries to defend: brand name, generic name, brand plus side effects, cost, savings, how to take, reviews.
- Condition queries to earn: symptoms, diagnosis, treatment options, questions to ask a doctor.
- Comparison queries, such as brand versus another brand. Handle these with great care, because a comparative claim needs substantiation and review.
Side effect searches deserve special attention. If your branded site does not have a clear, approved page on side effects, the searcher will read about them somewhere else.
Technical SEO for pharma sites
- Important Safety Information as HTML text, not an image, so it is readable by search engines and screen readers.
- Prescribing information as a web page as well as the PDF, where your regulatory team allows, so its content is indexable.
- HCP gates that allow an indexable summary page outside the gate, so the portal can rank at all.
- Structured data. Schema.org has a Drug type under MedicalEntity, and organisation markup ties the brand site to the manufacturer. Have every markup statement reviewed like the visible copy.
- Country versions. Approved indications differ by market, so use separate country pages with hreflang rather than one global page.
Working inside medical, legal and regulatory review
The fastest pharma SEO teams do not fight review. They design for it. Build a library of pre-approved claims and risk statements, get page templates approved once, and submit content in batches on a fixed calendar. Our guide to digital marketing for pharmaceutical companies covers the review process and the channel rules in more detail.
Choosing a pharmaceutical SEO agency
Ask any pharmaceutical SEO agency or consultant:
- Which pharma or healthcare brands have you worked on, and in which markets?
- How do you work with medical, legal and regulatory review, and how long does your typical page take to approve?
- Do you have medical writers, or do you rely on our team for clinical accuracy?
- How will you separate branded and unbranded work?
- What will you report: rankings and traffic, or also support-page use, savings card sign-ups and HCP registrations?
Our comparison of health care marketing agencies explains how the review chain decides which kind of shop fits.
Questions about pharma SEO
Is SEO allowed for prescription drugs?
Yes. Branded pages are promotional material, so your regulatory team reviews them for fair balance and risk information like any other asset, and optimising them for search is normal practice.
Why can pharma companies not just use Google Ads instead?
Google restricts prescription drug terms in ad text, landing pages and keywords, allows manufacturer ads only in select locations, and requires certification. Organic search fills the gap.
What is unbranded pharma SEO?
Content about a condition or disease that does not promote a specific product. It reaches patients before they know a brand name and is usually where most of the search demand sits.
How should pharma SEO be planned?
Longer than in most industries, because review adds weeks to each page. Plan in quarters, with batches of approved pages, rather than in weekly blog posts.
Should pharma sites name medical reviewers?
Yes. A named, qualified reviewer and a review date help readers trust the page, and they match what Google says it looks for in health content.
When a patient asks an assistant about the condition
A patient who has just heard a diagnosis increasingly asks ChatGPT or Gemini what the treatment options are, and the answer is assembled from the pages those assistants trust, often without a single search result being clicked. Whether your approved, balanced information is among those sources is worth knowing, and it is measured differently from rankings. AI Knows Us checks what assistants say when patients ask about a condition and which sources they lean on, so a brand team can see whether its reviewed content is the content being read.